Related references
Note: Only part of the references are listed.S-propargyl-cysteine (ZYZ-802), a sulphur-containing amino acid, attenuates beta-amyloid-induced cognitive deficits and pro-inflammatory response: involvement of ERK1/2 and NF-κB pathway in rats
Qi-Hai Gong et al.
AMINO ACIDS (2011)
Phosphodiesterase-4D Knock-Out and RNA Interference-Mediated Knock-Down Enhance Memory and Increase Hippocampal Neurogenesis via Increased cAMP Signaling
Yun-Feng Li et al.
JOURNAL OF NEUROSCIENCE (2011)
Apoptosis Inhibition Can Be Threatening in A beta-Induced Neuroinflammation, Through Promoting Cell Proliferation
A. Abdi et al.
NEUROCHEMICAL RESEARCH (2011)
Attenuation of NF-kappa B and activation of Nrf2 signaling by 1,2,4-triazine derivatives, protects neuron-like PC12 cells against apoptosis
Solaleh Khoramian Tusi et al.
APOPTOSIS (2010)
Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitors
Andrew F. Donnell et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation
L. SEKUT et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Immune-Inflammatory Responses and Oxidative Stress in Alzheimers Disease: Therapeutic Implications
D. Bona et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Paula Agostinho et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Neurotrophins Enhance CaMKII Activity and Rescue Amyloid-beta-Induced Deficits in Hippocampal Synaptic Plasticity
Yan Zeng et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Calcium Signaling and Amyloid Toxicity in Alzheimer Disease
Angelo Demuro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Adiponectin inhibits palmitate-induced apoptosis through suppression of reactive oxygen species in endothelial cells: involvement of cAMP/protein kinase A and AMP-activated protein kinase
Ji-Eun Kim et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Active Immunization with Amyloid-β 1-42 Impairs Memory Performance through TLR2/4-Dependent Activation of the Innate Immune System
Patrick Vollmar et al.
JOURNAL OF IMMUNOLOGY (2010)
PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K/Akt-dependent and NF-κB-independent manner
Lirlandia P. Sousa et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Inflammatory, Apoptotic, and Survival Gene Signaling in Alzheimer's Disease
Walter J. Lukiw et al.
MOLECULAR NEUROBIOLOGY (2010)
Membrane Biophysics and Mechanics in Alzheimer's Disease
Xiaoguang Yang et al.
MOLECULAR NEUROBIOLOGY (2010)
Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety
Alex B. Burgin et al.
NATURE BIOTECHNOLOGY (2010)
Val8-GLUCAGON-LIKE PEPTIDE-1 PROTECTS AGAINST Aβ1-40-INDUCED IMPAIRMENT OF HIPPOCAMPAL LATE-PHASE LONG-TERM POTENTIATION AND SPATIAL LEARNING IN RATS
X. H. Wang et al.
NEUROSCIENCE (2010)
Effects of trans-2,4-dimethoxystibene against the neurotoxicity induced by Aβ25-35 both in vitro and in vivo
Can-Jun Ruan et al.
NEUROSCIENCE RESEARCH (2010)
Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats
Yu-Fang Cheng et al.
PSYCHOPHARMACOLOGY (2010)
Discovery of selective PDE4B inhibitors
Kenji Naganuma et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation
Elin Hallan Naderi et al.
BLOOD (2009)
Leptin enhances growth inhibition by cAMP elevating agents through apoptosis of MDA-MB-231 breast cancer cells
Silvio Naviglio et al.
CANCER BIOLOGY & THERAPY (2009)
Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs
Han-Ting Zhang
CURRENT PHARMACEUTICAL DESIGN (2009)
Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus
Jun-ichi Satoh et al.
DISEASE MARKERS (2009)
Sleep deprivation impairs cAMP signalling in the hippocampus
Christopher G. Vecsey et al.
NATURE (2009)
Antidepressant- and Anxiolytic-like Effects of the Phosphodiesterase-4 Inhibitor Rolipram on Behavior Depend on Cyclic AMP Response Element Binding Protein-Mediated Neurogenesis in the Hippocampus
Yun-Feng Li et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Pharmacology of a Novel, Orally Active PDE4 Inhibitor
Sunanda G. Dastidar et al.
PHARMACOLOGY (2009)
Memory deficits and neurochemical changes induced by C-reactive protein in rats: implication in Alzheimer's disease
Huan-Bing Lin et al.
PSYCHOPHARMACOLOGY (2009)
Neuroinflammation: Implications for the pathogenesis and molecular diagnosis of Alzheimer's disease
Leonel E. Rojo et al.
ARCHIVES OF MEDICAL RESEARCH (2008)
Aβ(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels
R. Christensen et al.
EXPERIMENTAL NEUROLOGY (2008)
Sub-chronic rolipram treatment leads to a persistent improvement in long-term object memory in rats
K. Rutten et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
The effects of acute and repeated oroxylin A treatments on Aβ25-35-induced memory impairment in mice
Dong Hyun Kim et al.
NEUROPHARMACOLOGY (2008)
Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B)
Han-Ting Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Inflammatory changes parallel the early stages of Alzheimer disease
A. Parachikova et al.
NEUROBIOLOGY OF AGING (2007)
Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning
Christian Holscher et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Estrogen regulates Bcl-w and Bim expression:: Role in protection against β-amyloid peptide-induced neuronal death
Mingzhong Yao et al.
JOURNAL OF NEUROSCIENCE (2007)
Amyloid β-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo
Jian-Mei Zhang et al.
SYNAPSE (2006)
Protective effects of Glycyrrhiza uralensis Fisch on the cognitive deficits caused by β-amyloid peptide 25-35 in young mice
J. Ahn et al.
BIOGERONTOLOGY (2006)
Effects of pyrrolidine dithiocarbamate on beta-amyloid (25-35)-induced inflammatory responses and memory deficits in the rat
Guanliang Cheng et al.
NEUROBIOLOGY OF DISEASE (2006)
β-amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or β-amyloid deposits
Tarja Malm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid β and impairment of learning and memory
A Mouri et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Protective effect of Polygonum multiflorum Thunb on amyloid β-peptide 25-35 induced cognitive deficits in mice
MY Um et al.
JOURNAL OF ETHNOPHARMACOLOGY (2006)
Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action
K Rutten et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2006)
Subchronic Rolipram delivery activates hippocampal CREB and arc, enhances retention and slows down extinction of conditioned fear
B Monti et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Rolipram impairs NF-κB activity and MMP-9 expression in experimental autoimmune encephalomyelitis
AJ Sánchez et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Humanin delays apoptosis in K562 cells by downregulation of P38 MAP kinase
D Wang et al.
APOPTOSIS (2005)
Novel therapeutic opportunities for Alzheimer's disease:: focus on nonsteroidal anti-inflammatory drugs
KP Townsend et al.
FASEB JOURNAL (2005)
Tumor-necrosis-factor-related apoptosis-inducing-ligand (TRAIL)-mediated death of neurons in living human brain tissue is inhibited by flupirtine-maleate
J Dörr et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Effects of the novel PDE4 inhibitors MEM1018 and MEM1091 on memory in the radial-arm maze and inhibitory avoidance tests in rats
HT Zhang et al.
PSYCHOPHARMACOLOGY (2005)
Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)
JM O'Donnell et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Neurodegenerative diseases and oxidative stress
KJ Barnham et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task
M Giorgi et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Pathways towards and away from Alzheimer's disease
MP Mattson
NATURE (2004)
Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus
HT Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation
M Ariga et al.
JOURNAL OF IMMUNOLOGY (2004)
Mycelial extract of Cordyceps ophioglossoides prevents neuronal cell death and ameliorates β-amyloid peptide-induced memory deficits in rats
DQ Jin et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Aβ(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, a metabolite of protopanaxadiol-type saponins
C Tohda et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Molecular pathogenesis of neuroinflammation
M Bradl et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
A mouse model of Rubinstein-Taybi syndrome: Defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4
R Bourtchouladze et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats
MY Stepanichev et al.
BRAIN RESEARCH BULLETIN (2003)
Targeting the CREB pathway for memory enhancers
T Tully et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling
M Conti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization
MD Houslay et al.
BIOCHEMICAL JOURNAL (2003)
Propentofylline protects β-amyloid protein-induced apoptosis in cultured rat hippocampal neurons
Y Koriyama et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions
C Borner
MOLECULAR IMMUNOLOGY (2003)
Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation:: Reversibility by drugs that enhance cAMP signaling
OV Vitolo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Amyloid precursor protein, presenilins, and α-synuclein:: Molecular pathogenesis and pharmacological applications in Alzheimer's disease
YH Suh et al.
PHARMACOLOGICAL REVIEWS (2002)
Function and regulation of CREB family transcription factors in the nervous system
BE Lonze et al.
NEURON (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Acetyl-L-carnitine protects against amyloid-beta neurotoxicity: Roles of oxidative buffering and ATP levels
S Dhitavat et al.
NEUROCHEMICAL RESEARCH (2002)
Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses
SLC Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Angiotensin II promotes the phosphorylation of cyclic AMP-responsive element binding protein (CREB) at Ser133 through an ERK1/2-dependent mechanism
M Cammarota et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Possible new role for NF-κB in the resolution of inflammation
T Lawrence et al.
NATURE MEDICINE (2001)
Interleukin-1, neuroinflammation, and Alzheimer's disease
RE Mrak et al.
NEUROBIOLOGY OF AGING (2001)
Prion protein protects human neurons against Bax-mediated apoptosis
Y Bounhar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia
GM Pasinetti
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and-7 in distinct modes
Y Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation and function of the p53 tumor suppressor protein
KM Ryan et al.
CURRENT OPINION IN CELL BIOLOGY (2001)
β-Amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised
LQ Tong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Memory deficits and increased emotionality induced by beta-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus
A Olariu et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and [3H]rolipram binding autoradiography -: Comparison with monkey and rat brain
S Pérez-Torres et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2000)
Tumor necrosis factor has positive and negative self regulatory feed back cycles centered around cAMP
RE Kast
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY (2000)
Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism
HT Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia
JD Luterman et al.
ARCHIVES OF NEUROLOGY (2000)
Induction of cytokines in glial cells surrounding cortical β-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology
G Mehlhorn et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2000)
Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats
HT Zhang et al.
PSYCHOPHARMACOLOGY (2000)
Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
Y Yang et al.
SCIENCE (2000)
Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression
BY Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors
JE Souness et al.
IMMUNOPHARMACOLOGY (2000)
Share Paper
